Back
Intapp, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Sell
28
INTA
Intapp, Inc.
Last Price:
$43.23
Seasonality Move:
11.57%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$70.77
Seasonality Move:
20.18%
Sell
28
Intapp, Inc. (INTA)
is a Sell
Is Intapp, Inc. a Buy, Sell or Hold?
-
The current Intapp, Inc. [INTA] share price is $43.24. The Score for INTA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
INTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $70.82. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INTA Stock Price Chart
What is Intapp, Inc.'s stock price today?
-
The Intapp, Inc. share price today is $43.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INTA is experiencing slight buying pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $70.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
INTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.81 | Buy |
| Relative Strength Index (14 RSI): | 56.14 | Buy |
| Chaikin Money Flow: | 107183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.43 - 43.65) | Buy |
| Bollinger Bands (100): | (38.81 - 44.09) | Buy |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.95 | Buy |
| Relative Strength Index (14 RSI): | 77.46 | Buy |
| Chaikin Money Flow: | 740828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.92 - 62.36) | Buy |
| Bollinger Bands (100): | (20.46 - 47.52) | Buy |
INTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.5 | Sell |
| 20-day SMA: | 42.47 | Buy |
| 50-day SMA: | 40.34 | Buy |
| 200-day SMA: | 48.09 | Sell |
| 8-day EMA: | 43.12 | Buy |
| 20-day EMA: | 42.41 | Buy |
| 50-day EMA: | 41.72 | Buy |
| 200-day EMA: | 45.99 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.78 | Buy |
| 20-day SMA: | 53.22 | Buy |
| 50-day SMA: | 44.33 | Buy |
| 200-day SMA: | 24.55 | Buy |
| 8-day EMA: | 65.16 | Buy |
| 20-day EMA: | 56.66 | Buy |
| 50-day EMA: | 46.43 | Buy |
| 200-day EMA: | 30.4 | Buy |
Intapp, Inc. Earnings Growth & INTA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $0.27 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Intapp, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||